Jump to content
Research Peptides US A plain-English orientation to the most-studied research peptides across tissue repair, the growth-hormone axis, metabolic, longevity, immune and cognitive research — what each one is, how it works, and what the literature actually shows.

RESEARCH PEPTIDE FUNDAMENTALS / COLOPHON

Contact the Editorial Desk

Correspondence on citations, corrections, and newly published research — the things a reference desk is actually useful to hear about.

Editorial correspondence

The survey takes corrections seriously: a citation quoted inaccurately, a trial that has since published fresh results, a regulatory status update, or a peer-reviewed study on any of the five compounds that belongs on the references page. This is the single most useful kind of message it receives, and every one is read.

The quickest-actioned notes name the exact page, quote the exact passage at issue, and attach a supporting reference — a DOI or PubMed identifier where possible — so the change can be checked against its source before anything is edited.

Editorial mailbox: editors@researchpeptidesus.com

Outside the survey

So no message goes unanswered for the wrong reason: Research Peptides US is a literature survey, not a clinical service or a seller. It cannot advise on human use of any compound here, suggest a dose or schedule for anyone, judge whether a cited trial applies to a specific person, or sell, source, or help locate any compound from any supplier. It cannot advise athletes on anti-doping status either.

Tirzepatide is a prescription medicine. Retatrutide is investigational and not legally available outside clinical trials. BPC-157 and KPV are unregulated research chemicals with no approved human use. Readers seeking medical guidance should consult a licensed clinician. Replies to editorial correspondence are not guaranteed and may be delayed.